CompletedNCT00299507
Anecortave Acetate in Patients With Exudative Age-related Macular Degeneration (AMD)
PHASE3 · 240 planned enrolment
- Countries listed
- 1
- Registry update
- November 28, 2012
immortal.lifeTrial registrations containing the exact intervention label Anecortave Acetate Vehicle.
No aliases or equivalent products have been inferred.
This is a registry availability fact, not a safety result, comparison, or conclusion.
Understand the safety boundary →PHASE3 · 240 planned enrolment
PHASE3 · 291 planned enrolment
PHASE2 · 128 planned enrolment